Loading...
Symbols:
Loading...
Symbols:
Covance Inc. (CVD)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Covance Inc. (CVD)
22 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on CVD
- ChinaBio Today(8)
- SA Editor Miriam Metzinger(5)
- Robert Freedland(3)
- SA Editor Joan Wickham(3)
- Trader Mark(2)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(576)
- Trader Mark(492)
- SA Editor Joan Wickham(145)
- Alan Brochstein(132)
- SA Editor Miriam Metzinger(120)
Most commented on authors
- Recent Russell 3000 Movers
- China Bio Week in Review: October Finally Over
- Covance Taking China Growth Slowly
- Down to Three Positions, I'm Ready for End of Bear Market
- Market Behaves Sanely - Fast Money Recap (10/14/08)
- My Wild Week of Trading
- Global Payments Rated a Hold
- China Biotech in Review: Deals and Earnings
- Wuxi Pharma Drops on News of Deal Dissolution with Covance
- CROs: The 'Big Pharma Effect'
- WuXi: Solid Earnings, Solid Outlook
- Stocks At or Near 52-Week Highs
- Eli Lilly Sells Lab Site to Covance
- China Biotech in Review: A Week of Collaborations
- WuXi Partners with Covance on Contract Research Services in China
- Earnings Review: Ignoring Media and Government Reports
- Contract Research Organizations Are Weak Again
- Jim Cramer Mad Money In-Depth, 1/14/08: What the Tech
- Covance, Pharmaceutical Product Development Good Bets - Barron's
- Chinese Biotech Week in Review: Covance Advances on its Shanghai Lab
- Fourteen Stocks Ready to Break Out
- Why I Bought Covance (Again)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »